Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Highlights
Working documents in public consultation
WHO norms and standards for pharmaceuticals: working documents under reviewEvents
All →Expert Committees
Advisory groups
Publications
All →
16 April 2025
WHO Drug Information - Volume 39, No. 1
The first issue of volume 39 for 2025 includes:Consultation Documents: - "Aminosalicylate sodium dihydrate (aminosalicylatum natricum dihydricus)"- "Aminosalicylate...
15 April 2025
TRS 1060 - 58th report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations
The Expert Committee on Specifications for Pharmaceutical Preparations works towards clear, independent and practical standards and guidelines for...
The Forty-seventh Meeting of the World Health Organization (WHO)’s Expert Committee on Drug Dependence (ECDD) was convened from 14 to 18 October...
14 February 2025
WHO Drug Information - Volume 38, No. 4
The fourth and last issue of volume 38 includes:Regulatory News: "19th International Conference of Drug Regulatory Authorities (ICDRA) proceedings...
Journal articles
Disease foci of pharmaceutical research and development as reflected in applications for International Nonproprietary Names, 1953–2022
Bulletin of the World Health Organization, Volume 103, Number 1, January 2025 1-80
WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products
Frontiers in Medicine, 23 September 2024 Sec. Regulatory Science
New WHO INN for cell-based and gene-based substances: timing, usage, and simplicity
The Lancet, Correspondence| Volume 404, Issue 10460, P1302-1303,October 05, 2024